Spinal Muscular Atrophy Trial, Recruiting NCT06363357 Sponsor: Seoul National University Hospital Condition: Spinal Muscular Atrophy
Back to Spinal Muscular Atrophy

Spinal Muscular Atrophy Trial, Recruiting

NCT06363357
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been formally diagnosed with a neuromuscular disease (such as muscular dystrophy, spinal muscular atrophy, ALS, Charcot-Marie-Tooth disease, or a similar condition affecting the muscles or nerves), confirmed through genetic testing, a muscle biopsy, or nerve/muscle tests, and your arms are notably weak as a result.
  • You are older than 10 years of age.
  • Your upper arm and hand function falls within a specific middle range on a standard medical rating scale called the Brooke Upper Extremity Functional Rating Scale, scoring between 2 and 5 (confirm with trial site).
  • You have significant weakness in your shoulder, specifically scoring below a certain level on a standard muscle strength test called the Manual Muscle Test (confirm with trial site).
  • You (or your legal guardian or representative) are able and willing to sign a consent form agreeing to take part in the study.

Who may not be able to join:

  • You are unwilling or unable to give your consent (or have someone give it on your behalf) to take part.
  • Your score on the Brooke Upper Extremity Functional Rating Scale is at either extreme — a 1 or a 6 (confirm with trial site).
  • You have significant memory or thinking difficulties that would stop you from being able to use a shoulder support device properly.
  • You have any other health condition that the trial doctor believes would make it unsafe or unsuitable for you to take part.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Woo Hyung Lee, MD, PhD, Seoul National University Hospital

Phone: +82-10-9381-2299

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 April 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Performance of the upper limb module 2.0 (PUL 2.0); Active Range of motion; Functional workspace; Goal Attainment Scale (GAS); Surface electromyography (sEMG); Heart rate; Blood pressure; Numeral Rating Scale for Pain; Box and block test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov